Tetradrip Pharma Private Limited, a active private limited company, was established on 17 April 2013 in Burdwan, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33111WB2013PTC192301. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹6.19 Cr.
It upholds a compliant status. Employing 69 professional, Its leadership includes Manoj Gupta (Director), Swati Gupta (Director). Past directors included Arvind Khaitan, Abhishek Saraogi, Vikas Poddar. It holds ₹4.23 Cr open charges and ₹4.23 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Vill P.O.- Barakashiara, Dist.- Burdwan, Burdwan, West Bengal, 713141.
U33111WB2013PTC192301
192301
17 April 2013
₹12.00 Cr
₹6.19 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Tetradrip Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Gupta | Director | 06 Dec 2019 | Current |
| Swati Gupta | Director | 06 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Sep 2021 | Past |
| Pramod Abcsdd | Director | 30 Aug 2021 | Past |
| Pramod Abcsdd | Director | 06 Dec 2019 | Past |
| Pramod Abcsdd | Director | 06 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 17 Dec 2020 | Past |
| Pramod Abcsdd | Director | 06 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tetradrip Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 507.63% increase. The company also saw a substantial improvement in profitability, with a 104.45% increase in profit. The company's net worth Soared by an impressive increase of 18.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Tetradrip Pharma had a promoter holding of 88.00% and a public holding of 12.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹42,274,000.00
₹42,274,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2015 | Others | ₹4.23 Cr | Satisfied |
Explore comprehensive loan charge details -
Tetradrip Pharma has a workforce of 69 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Tetradrip Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tetradrip Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 27 Aug 2015 via Charge ID 10611540 with Others was fully satisfied on 06 Jun 2025. was completed.
Progress on Tetradrip Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Tetradrip Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on A charge with Others of Rs. 4.23 Cr registered on 27 Aug 2015 with Charge ID 10611540 was modified on 20 Feb 2023. was documented.
Manoj Gupta was appointed as a Director was appointed as a Director on 06 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
Swati Gupta was appointed as a Director was appointed as a Director on 06 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The CIN of Tetradrip Pharma Private Limited is U33111WB2013PTC192301.
Tetradrip Pharma Private Limited is headquartered at Vill P.O.- Barakashiara, Dist.- Burdwan, Burdwan, West Bengal, 713141.
Tetradrip Pharma Private Limited was incorporated on 17 April 2013.
The current directors of Tetradrip Pharma Private Limited are
The primary industry of Tetradrip Pharma Private Limited is Manufacturing.
Tetradrip Pharma Private Limited is unlisted.
The authorized capital of Tetradrip Pharma Private Limited is ₹12.00 Cr, and the paid-up capital is ₹6.19 Cr.
The compliance status of Tetradrip Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX